Lixte Biotechnology Holdings, Inc. (LIXT) Q1 2025 Earnings
LIXT·Reported May 12, 2025·Before market open
Diluted EPS came in at $-0.29 (+32.6% YoY).
Diluted EPS
$-0.29
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Lixte Biotechnology Holdings, Inc.'s Q1 2025 earnings report.
Lixte Biotechnology Holdings, Inc. (LIXT) reported Q1 2025 earnings on May 12, 2025 before market open.
Lixte Biotechnology Holdings, Inc. reported diluted EPS of $-0.29 for Q1 2025.
Compared to the same quarter a year prior, diluted EPS grew 32.6% from $-0.43.
You can read the 10-Q periodic report (0001641172-25-009575) directly on SEC EDGAR. The filing index links above go to sec.gov.